Lumigan 0.03%

Forms and dosages

Lumigan is administered as one drop in the affected eye(s) once daily, ideally in the evening. According to the prescribing information, more frequent dosing reduces rather than enhances the pressure-lowering effect. Multiple ophthalmic medications should be separated by at least 5 minutes. Contact lenses should be removed before administration and may be reinserted 15 minutes later.

Indications

Lumigan is approved in adults for the reduction of elevated intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension. According to international guidelines, prostaglandin analogues such as bimatoprost are typically first-line therapy for newly diagnosed glaucoma because of their efficacy, once-daily dosing and favourable systemic safety profile. Combination with other agents is considered when the target intraocular pressure is not achieved with monotherapy.